Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v3.4.0.3
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Apr. 30, 2016
Apr. 30, 2015
Income Statement [Abstract]        
Revenue
Expenses:        
Research and development $ 3,376,757 $ 3,932,322 $ 11,149,652 $ 9,293,484
General and administrative 2,874,362 2,053,964 9,174,406 5,371,245
Loss from operations (6,251,119) (5,986,286) (20,324,058) (14,664,729)
Provision for income taxes 290 1,059 2,462 1,969
Net loss $ (6,251,409) $ (5,987,345) $ (20,326,520) $ (14,666,698)
Basic net loss per common share $ (0.37) $ (0.48) $ (1.27) $ (1.19)
Diluted net loss per common share $ (0.37) $ (0.48) $ (1.27) $ (1.19)
Weighted average shares used in computing basic net loss per common share 16,971,214 12,349,693 15,955,116 12,347,450
Weighted average shares used in computing diluted net loss per common share 16,971,214 12,349,693 15,955,116 12,347,450